Patient experience surveys exempted from national data opt-outs

  • 21 January 2019
Patient experience surveys exempted from national data opt-outs

Users of the national data opt-out service will need to separately opt out of national patient surveys, it has been announced.

Speaking on Twitter, health minister Steve Brine argued that “learning from the experiences of patients is crucial to shape services”.

It was for that reason, he said, that the national data opt-out – a means by which people can prevent their confidential patient data from being used for research and planning purposes – would not automatically apply to national patient surveys.

That includes, notably, the National Cancer Patient Experience Survey.

https://twitter.com/BrineMinister/status/1083303131000328195

The national data opt-out programme was launched in May last year with a view to allowing people to choose how their confidential health data is used.

It replaces the previous ‘type 2’ opt-out, which allowed patients to tell NHS Digital they did not want their data shared for purposes other than their direct care.

But what was covered by the opt-out caused concern among some bodies.

In August 2017 Cancer Research UK and Macmillan Cancer Support wrote to then-health secretary Jeremy Hunt arguing that applying the opt-out system to cancer experience surveys would jeopardise improvement in care.

Responding to the decision, Matt Case, from Cancer Research UK, said: “This is absolutely the right decision to ensure we to continue to improve the NHS.

“Every year the Cancer Patient Experience Survey gathers the views of tens of thousands of people with cancer.

“It provides a rich insight into their experience from diagnosis to treatment and clear evidence of how to improve cancer services.”

Dr Fran Woodard, executive director of policy and impact at Macmillan Cancer Support, said it was a “really positive decision”.

“Given that the information is a leading source of evidence for the patient experience, access to the data plays a vital role in monitoring quality and improving patient care,” she added.

“It is important that we keep up the national conversation around how bodies like the NHS use personal data volunteered by the public to better understand and advance care, which is essential for driving improvement.”

The opt-out programme currently only covers data held by NHS Digital. But all organisations that use health and care information will be required to respect any national opt-outs by March 2020.

The programme was implemented last May, following the introduction of the general data protection regulation (GDPR) and recommendations from the National Data Guardian in light of controversies around the care.data programme.

That project aimed to expand the Hospital Episode Statistics (HES) database – which contains details of all admissions, A&E attendances and outpatient appointments at NHS hospitals in England – by linking it to other data sets, starting with GP data.

However it was quickly met with heavy criticism for confusion over what the data would be used for and how patients could opt out.

The project was eventually dropped in July 2016 following the release of Dame Fiona Caldicott’s report on security and information governance in the NHS.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Digital Health Coffee Time Briefing ☕

Digital Health Coffee Time Briefing ☕

This edition of Coffee Time includes Birdie being named one of the 500 fastest-growing tech companies and development of AI tech to predict heart events.
Digital Health Coffee Time Briefing ☕

Digital Health Coffee Time Briefing ☕

Thursday's briefing features healthcare communications provider Cymphony reaching net-zero carbon status and Apotti's new learning platform for its EHR.
Digital Health Coffee Time Briefing ☕    

Digital Health Coffee Time Briefing ☕   

This briefing features Holly Health partnering with Loughborough University to deliver multimorbidity app Prevent and Pharmacy2u acquiring the PharmPet Co.

4 Comments

  • It is important to note that the Section 251 support in place for some national patient surveys will be watered-down by this. For long enough CAG has required that if Section 251 support is provided then individuals should be given the option to opt out.

    I can’t therefore help but feel this is watering down individual rights due to clumsy led by politicians/NHSE decisions about what National Opt-out looks like.

    Also please can all reader note this only applies to NATIONAL patient surveys and not local ones. I’ve already seen this being seen as a green-light to all surveys.

  • “The opt-out programme currently only covers data held by NHS Digital” – disease registers held by Public Health England are also covered by the National Data Opt-out – these were added in a few months ago.

    • The disease registers ARE NOT covered by the National Opt Out. Either the National Opt Out should include everything, give you the option of including everything, or there needs to be a definitive list of what it does not cover.
      It makes a mockery of data protection and patient rights when the NHS/Public Health England make it up as they go along, and it appears the National Data Guardian us going to turn into a puppet.

  • When people opt-out, they expect their decision to be respected. There’s no point having the National Opt-Out if the NHS is going to pick and chose when it applies.

Comments are closed.